4//SEC Filing
DeMuth Peter 4
Accession 0001601485-24-000051
CIK 0001601485other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:13 PM ET
Size
5.7 KB
Accession
0001601485-24-000051
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-30+29,800→ 29,800 totalExercise: $5.03Exp: 2024-09-30→ Common Stock (29,800 underlying)
Footnotes (1)
- [F1]Fifty percent (50%) of the stock options vest on September 30, 2025, the one-year anniversary of the grant date, with the remaining fifty percent (50%) of the stock options to vest on September 30, 2026, the two-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001979163
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:13 PM ET
- Size
- 5.7 KB